About FDA
Average number of days from receipt of high priority inspection assignment to investigator initiating the inspection
Dictionary: High priority inspection assignments are defined as: 1) Public health emergency (e.g., outbreak, trace-back), 2) User fee driven (e.g., PDUFA, MDUFMA), 3) For cause (e.g., follow-up to a compliance issue, complaint, adverse event), 4) Impending critical patent expiry, or 5) Special request
Information is current as of February 12, 2013.
Fiscal Year - 2012
| Time | Target | Average number of days |
|---|---|---|
| Oct 2011 | N/A | N/A |
| Nov 2011 | N/A | N/A |
| Dec 2011 | N/A | N/A |
| Jan 2012 | N/A | N/A |
| Feb 2012 | N/A | N/A |
| Mar 2012 | N/A | N/A |
| Apr 2012 | N/A | 14 |
| May 2012 | N/A | 19 |
| Jun 2012 | N/A | 23 |
| Jul 2012 | N/A | 17 |
| Aug 2012 | N/A | 11 |
| Sep 2012 | N/A | 10 |
Measure implemented April 2012
Footnotes
- Measure tracked in calendar days
Average number of days from investigator initiating the high priority inspection (entering the firm) to investigator completing the inspection
Dictionary: High priority inspection assignments are defined as: 1) Public health emergency (e.g., outbreak, trace-back), 2) User fee driven (e.g., PDUFA, MDUFMA), 3) For cause (e.g., follow-up to a compliance issue, complaint, adverse event), 4) Impending critical patent expiry, or 5) Special request
Fiscal Year - 2012
| Time | Target | Average number of days |
|---|---|---|
| Oct 2011 | N/A | N/A |
| Nov 2011 | N/A | N/A |
| Dec 2011 | N/A | N/A |
| Jan 2012 | N/A | N/A |
| Feb 2012 | N/A | N/A |
| Mar 2012 | N/A | N/A |
| Apr 2012 | N/A | 5 |
| May 2012 | N/A | 11 |
| Jun 2012 | N/A | 3 |
| Jul 2012 | N/A | 6 |
| Aug 2012 | N/A | 5 |
| Sep 2012 | N/A | 4 |
Measure implemented April 2012
Footnotes
- Measure tracked in calendar days
Average number of days from investigator completing the high priority inspection to investigator submitting the report to headquarters
Dictionary: High priority inspection assignments are defined as: 1) Public health emergency (e.g., outbreak, trace-back), 2) User fee driven (e.g., PDUFA, MDUFMA), 3) For cause (e.g., follow-up to a compliance issue, complaint, adverse event), 4) Impending critical patent expiry, or 5) Special request
Fiscal Year - 2012
| Time | Target | Average number of days |
|---|---|---|
| Oct 2011 | N/A | N/A |
| Nov 2011 | N/A | N/A |
| Dec 2011 | N/A | N/A |
| Jan 2012 | N/A | N/A |
| Feb 2012 | N/A | N/A |
| Mar 2012 | N/A | N/A |
| Apr 2012 | N/A | 24 |
| May 2012 | N/A | 31 |
| Jun 2012 | N/A | 29 |
| Jul 2012 | N/A | 19 |
| Aug 2012 | N/A | 12 |
| Sep 2012 | N/A | 18 |
Measure implemented April 2012
Footnotes
- Measure tracked in calendar days
Average number of days from investigator initiating the routine inspection (entering the firm) to investigator completing the inspection
Dictionary: Routine inspection assignments are defined as those that are received from the Centers as "surveillance" work at the beginning of the Fiscal Year
Fiscal Year - 2012
| Time | Target | Average number of days |
|---|---|---|
| Oct 2011 | N/A | N/A |
| Nov 2011 | N/A | N/A |
| Dec 2011 | N/A | N/A |
| Jan 2012 | N/A | N/A |
| Feb 2012 | N/A | N/A |
| Mar 2012 | N/A | N/A |
| Apr 2012 | N/A | 3 |
| May 2012 | N/A | 2 |
| Jun 2012 | N/A | 3 |
| Jul 2012 | N/A | 6 |
| Aug 2012 | N/A | 4 |
| Sep 2012 | N/A | 1 |
Measure implemented April 2012
Footnotes
- Measure tracked in calendar days
Average number of days from investigator completing the routine inspection to investigator submitting the report to headquarters
Dictionary: Routine inspection assignments are defined as those that are received from the Centers as "surveillance" work at the beginning of the Fiscal Year
Fiscal Year - 2012
| Time | Target | Average number of days |
|---|---|---|
| Oct 2011 | N/A | N/A |
| Nov 2011 | N/A | N/A |
| Dec 2011 | N/A | N/A |
| Jan 2012 | N/A | N/A |
| Feb 2012 | N/A | N/A |
| Mar 2012 | N/A | N/A |
| Apr 2012 | N/A | 55 |
| May 2012 | N/A | 8 |
| Jun 2012 | N/A | 14 |
| Jul 2012 | N/A | 28 |
| Aug 2012 | N/A | 28 |
| Sep 2012 | N/A | 16 |
Measure implemented April 2012
Footnotes
- Measure tracked in calendar days
Glossary
Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.







